NovaBridge Biosciences (NBP) EPS (Basic) (2019 - 2025)

NovaBridge Biosciences (NBP) reported EPS (Basic) of -$0.33 for Q4 2025, up 100.0% year-over-year from -$0.17 in Q4 2024, and up 100.0% quarter-over-quarter from -$85350.0 in Q3 2025.

NovaBridge Biosciences (NBP) EPS (Basic) (2019 - 2025) Analysis & Trends

NovaBridge Biosciences (NBP) has 5 years of EPS (Basic) data on file, last reported at -$0.33 in Q4 2025.

  • EPS (Basic) for Q4 2025 came in at -$0.33, up 100.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$352930.3 (down 30.4% YoY), and the FY2025 annual result was -$0.21, up 22.22% from the prior year.
  • EPS (Basic) rose to -$0.33 in Q4 2025 per NBP's latest filing, from -$85350.0 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $251260.0 in Q2 2024 and troughed at -$286366.7 in Q4 2024.
  • A 3-year average of -$62357.3 and a median of -$91463.1 in 2024 frame the typical range for EPS (Basic).
  • On a YoY basis, EPS (Basic) climbed as much as 78211709.93% in 2024 and fell as far as 56605400.42% in 2024.
  • A 3-year view of EPS (Basic) shows it stood at $0.17 in 2023, then sank by 166125372.13% to -$286366.7 in 2024, then jumped by 100.0% to -$0.33 in 2025.
  • Business Quant data shows NBP's EPS (Basic) at -$0.33 in Q4 2025, -$85350.0 in Q3 2025, and -$110080.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -0.68
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 3.06
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 0.00
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 0.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 0.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 0.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 4.06
9 Abivax 90.15 Bn 90.15 Bn - -0.06
10 NovaBridge Biosciences 328.19 Mn 117.34 Mn - -0.33

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.33
Sep 30, 2025 -85,350.00
Jun 30, 2025 -110,080.00
Mar 31, 2025 -157,500.00
Dec 31, 2024 -286,366.67
Sep 30, 2024 -97,576.19
Jun 30, 2024 251,260.00
Mar 31, 2024 -137,960.00
Sep 30, 2023 0.17
Jun 30, 2023 -0.32
Dec 31, 2020 296,737.89
Sep 30, 2020 -0.78
Dec 31, 2019 -51.70